Skip to main content
×
Home
    • Aa
    • Aa
  • Access
  • Cited by 11
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Mamtani, Manju Kulkarni, Hemant Dyer, Thomas D. Göring, Harald H. H. Neary, Jennifer L. Cole, Shelley A. Kent, Jack W. Kumar, Satish Glahn, David C. Mahaney, Michael C. Comuzzie, Anthony G. Almasy, Laura Curran, Joanne E. Duggirala, Ravindranath Blangero, John and Carless, Melanie A. 2016. Genome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families. Clinical Epigenetics, Vol. 8, Issue. 1,


    Pandit, Abha and Pandey, Abhay Kumar 2016. Atherosclerosis: Current perspectives. Apollo Medicine, Vol. 13, Issue. 1, p. 10.


    Pihlajamäki, Jussi Schwab, Ursula Kaminska, Dorota Ågren, Jyrki Kuusisto, Johanna Kolehmainen, Marjukka Paananen, Jussi Laakso, Markku and Uusitupa, Matti 2015. Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial. Genes & Nutrition, Vol. 10, Issue. 6,


    Sofer, Sigal Eliraz, Abraham Madar, Zecharia and Froy, Oren 2015. Concentrating carbohydrates before sleep improves feeding regulation and metabolic and inflammatory parameters in mice. Molecular and Cellular Endocrinology, Vol. 414, p. 29.


    Cornelis, Marilyn C. 2014. Gene-Diet Interactions in Type 2 Diabetes. Current Nutrition Reports, Vol. 3, Issue. 4, p. 302.


    García-Broncano, Pilar Berenguer, Juan Fernández-Rodríguez, Amanda Pineda-Tenor, Daniel Jiménez-Sousa, María Ángeles García–Alvarez, Mónica Miralles, Pilar Aldámiz-Echevarria, Teresa López, Juan Carlos Micheloud, Dariela and Resino, Salvador 2014. PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study. Journal of Translational Medicine, Vol. 12, Issue. 1,


    Park, J.Y. Lee, H.-J. Jang, H.B. Hwang, J.-Y. Kang, J.H. Han, B.-G. Lee, J.-Y. and Song, J. 2014. Interactions between ADIPOQ gene variants and dietary monounsaturated: saturated fatty acid ratio on serum lipid levels in Korean children. Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Issue. 1, p. 83.


    Isaak, Cara K. and Siow, Yaw L. 2013. The evolution of nutrition research. Canadian Journal of Physiology and Pharmacology, Vol. 91, Issue. 4, p. 257.


    Masi, Laureane N. Rodrigues, Alice C. and Curi, Rui 2013. Fatty acids regulation of inflammatory and metabolic genes. Current Opinion in Clinical Nutrition and Metabolic Care, p. 1.


    Pollin, Toni I. and Quartuccio, Michael 2013. What We Know About Diet, Genes, and Dyslipidemia: Is There Potential for Translation?. Current Nutrition Reports, Vol. 2, Issue. 4, p. 236.


    Dimitriou, Maria E. and Dedoussis, George V. Z. 2012. Gene–Diet Interactions in Cardiovascular Disease. Current Nutrition Reports, Vol. 1, Issue. 3, p. 153.


    ×
  • Proceedings of the Nutrition Society, Volume 71, Issue 1
  • February 2012, pp. 141-153

Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study

  • Aseel AlSaleh (a1), Thomas A. B. Sanders (a1) and Sandra D. O'Dell (a1)
  • DOI: http://dx.doi.org/10.1017/S0029665111003181
  • Published online: 01 November 2011
Abstract

Unsaturated fatty acids are ligands of PPAR-γ, which up-regulates genes involved in fatty acid transport and TAG synthesis and the insulin-sensitising adipokine adiponectin, which activates fatty acid β-oxidation via PPAR-α action in liver. We investigated the effect of dietary fatty acid interaction with PPARG, PPARA and ADIPOQ gene variants on plasma lipid and adiponectin concentrations in the Reading Imperial Surrey Cambridge King's study, a five-centre, parallel design, randomised controlled trial of 466 subjects at increased cardiometabolic risk. After a 4-week run-in to baseline, SFA was replaced by MUFA or carbohydrate (low fat) in isoenergetic diets for 24 weeks. Habitual dietary PUFA:SFA ratio×PPARG Pro12Ala genotype interaction influenced plasma total cholesterol (P=0·02), LDL-cholesterol (P=0·002) and TAG (P=0·02) concentrations in White subjects. PPARA Val162Leu×PPARG Pro12Ala genotype interaction influenced total cholesterol (P=0·04) and TAG (P=0·03) concentrations at baseline. After high-MUFA and low-fat diets, total cholesterol and LDL-cholesterol were reduced (P<0·001) and gene×gene interaction determined LDL-cholesterol (P=0·003) and small dense LDL as a proportion of LDL (P=0·012). At baseline, ADIPOQ −10066 G/A A-allele was associated with lower serum adiponectin (n 360; P=0·03) in White subjects. After the high-MUFA diet, serum adiponectin increased in GG subjects and decreased in A-allele carriers (P=0·006 for difference). In GG, adiponectin increased with age after the high MUFA and decreased after the low-fat diet (P=0·003 for difference at 60 years). In conclusion, in Whites, high dietary PUFA:SFA would help to reduce plasma cholesterol and TAG in PPARG Ala12 carriers. In ADIPOQ −10066 GG homozygotes, a high-MUFA diet may help to increase adiponectin with advancing age.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study
      Your Kindle email address
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Ms Aseel AlSaleh, fax +44 20 7848 4171, email aseel.alsaleh@kcl.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1.KG Alberti , P Zimmet & J Shaw (2006) Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diab Med 23, 469480.

2.A Astrup , GK Grunwald , EL Melanson (2000) The role of low-fat diets in body weight control: A meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord 24, 15451552.

3.SE Feldeisen & KL Tucker (2007) Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab 32, 4660.

5.SM Grundy , N Abate & M Chandalia (2002) Diet composition and the metabolic syndrome: What is the optimal fat intake? Am J Med 113, Suppl. 9B, 25S29S.

6.G Riccardi , R Giacco & AA Rivellese (2004) Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23, 447456.

7.B Vessby , IB Gustafsson , S Tengblad (2002) Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 967, 183195.

8.LG Gillingham , S Harris-Janz & PJ Jones (2011) Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 46, 209228.

12.M Lehrke & MA Lazar (2005) The many faces of PPARgamma. Cell 123, 993999.

13.V Costa , MA Gallo , F Letizia (2010) PPARG: Gene expression regulation and next-generation sequencing for unsolved issues. PPAR Res 2010, pii: 409168.

14.HE Xu , MH Lambert , VG Montana (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3, 397403.

15.RK Semple , VK Chatterjee & S O'Rahilly (2006) PPARγ and human metabolic disease. J Clin Invest 116, 581589.

16.X Hua , C Yokoyama , J Wu (1993) SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 90, 1160311607.

17.HR Kast-Woelbern , SL Dana , RM Cesario (2004) Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis. J Biol Chem 279, 2390823915.

18.RB Goldberg (2006) Impact of thiazolidenediones on serum lipoprotein levels. Curr Atheroscler Rep 8, 397404.

20.F Ovalle & DS Bell (2002) Lipoprotein effects of different thiazolidinediones in clinical practice. Endocr Pract 8, 406410.

22.A Shah , DJ Rader & JS Millar (2010) The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans. Atherosclerosis 210, 3540.

23.P Tontonoz , L Nagy , JG Alvarez (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241252.

24.G Martin , K Schoonjans , AM Lefebvre (1997) Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J Biol Chem 272, 2821028217.

26.A Zieleniak , M Wojcik & LA Wozniak (2008) Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz) 56, 331345.

27.ML Tellechea , F Aranguren , MS Perez (2009) Pro12Ala polymorphism of the peroxisome proliferator activated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: Interaction with smoking status. Circ J 73, 21182124.

29.HN Gouda , GS Sagoo , AH Harding (2010) The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: A HuGE review and meta-analysis. Am J Epidemiol 171, 645655.

31.SS Deeb , L Fajas , M Nemoto (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20, 284287.

33.S Masud , S Ye & SAS Group (2003) Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: A meta-analysis. J Med Genet 40, 773780.

34.J Robitaille , JP Despres , L Perusse (2003) The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: Results from the Quebec Family Study. Clin Genet 63, 109116.

35.A Tonjes , M Scholz , M Loeffler (2006) Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Prediabetic phenotypes: Meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 29, 24892497.

36.X Huang , J Zhao & T Zhao (2011) Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: A meta-analysis. Atherosclerosis 215, 136144.

37.Y Mori , H Ikegami , Y Kawaguchi (2001) The Pro12Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50, 891894.

38.J Ringel , S Engeli , A Distler (1999) Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Biochem Biophys Res Commun 254, 450453.

39.R Meshkani , M Taghikhani , B Larijani (2007) Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. Clin Chem Lab Med 45, 477482.

40.A Vidal-Puig , M Jimenez-Linan , BB Lowell (1996) Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97, 25532561.

41.J Masugi , Y Tamori , H Mori (2000) Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun 268, 178182.

42.A Memisoglu , FB Hu , SE Hankinson (2003) Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes. Diabetes Care 26, 29152917.

43.J Luan , PO Browne , AH Harding (2001) Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50, 686689.

44.SA Jebb , JA Lovegrove , BA Griffin (2010) Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: The RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr 92, 748758.

45.V Lindi , U Schwab , A Louheranta (2003) Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol Genet Metab 79, 5260.

46.D Auboeuf , J Rieusset , L Fajas (1997) Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes 46, 13191327.

47.T Aoyama , JM Peters , N Iritani , (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273, 56785684.

48.M Yoon (2009) The role of PPARalpha in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARalpha actions. Pharmacol Res 60, 151159.

49.JC Corton , SP Anderson & A Stauber (2000) Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40, 491518.

51.SR Pyper , N Viswakarma , S Yu (2010) PPARalpha: Energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal 8, e002.

52.WJ Lee , M Kim , HS Park (2006) AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun 340, 291295.

53.Torra I Pineda , Y Jamshidi , DM Flavell (2002) Characterization of the human PPARalpha promoter: Identification of a functional nuclear receptor response element. Mol Endocrinol 16, 10131028.

54.B Staels , N Vu-Dac , VA Kosykh (1995) Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J Clin Invest 95, 705712.

58.B König , A Koch , J Spielmann (2007) Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem Pharmacol 73, 574585.

59.I Lemieux , H Salomon & JP Despres (2003) Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients. Ann Med 35, 442448.

60.B Staels , J Dallongeville , J Auwerx (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 20882093.

61.AK Golembesky , MD Gammon , KE North (2008) Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: A Long Island ancillary study. Carcinogenesis 29, 19441949.

62.ES Tai , S Demissie , LA Cupples (2002) Association between the PPARA L162V polymorphism and plasma lipid levels: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 22, 805810.

63.J Robitaille , C Brouillette , A Houde (2004) Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet 49, 482489.

64.T Sparsø , MS Hussain , G Andersen (2007) Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people. Mol Genet Metab 90, 205209.

65.J Uthurralt , H Gordish-Dressman , M Bradbury (2007) PPARα L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males. BMC Med Genet 8, 55.

66.MJ Shin , AM Kanaya & RM Krauss (2008) Polmorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. Atherosclerosis 198, 313319.

67.EM Nielsen , L Hansen , SM Echwald (2003) Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects. Pharmacogenetics 13, 417423.

68.DM Flavell , I Pineda Torra , Y Jamshidi (2000) Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia 43, 673680.

69.ES Tai , D Collins , SJ Robins (2006) The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: The Veterans Affairs HDL Intervention Trial (VA-HIT). Atherosclerosis 187, 153160.

71.G Silbernagel , N Stefan , MM Hoffmann (2009) The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition. Exp Clin Endocrinol Diabetes 117, 113318.

72.J Skogsberg , K Kannisto , TN Cassel (2003) Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscler Thromb Vasc Biol 23, 637643.

73.J Aberle , I Hopfer , FU Beil (2006) Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int J Obes Metab Disord 30, 17091713.

74.A Sapone , JM Peters , S Sakai (2000) The human peroxisome proliferator-activated receptor alpha gene: Identification and functional characterization of two natural allelic variants. Pharmacogenetics 10, 321333.

75.I Rudkowska , D Caron-Dorval , M Verreault (2010) PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity. Mol Nutr Food Res 54, 543550.

80.RB Goldberg , DM Kendall , MA Deeg (2005) A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 28, 15471554.

81.T Hamada , K Kotani , K Tsuzaki (2007) Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population. Metabolism 56, 13451349.

83.A Bouchard-Mercier , G Godin , B Lamarche (2011) Effects of peroxisome proliferator-activated receptors, dietary fat intakes and gene-diet interactions on peak particle diameters of low-density lipoproteins. J Nutrigenet Nutrigenomics 4, 3648.

84.MJ Caslake , CJ Packard , A Gaw (1993) Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia. Arterioscler Thromb 13, 702711.

85.KK Berneis & RM Krauss (2001) Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43, 13631379.

86.KW Oh , WY Lee , EJ Rhee (2005) The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 63, 131138.

87.T Isobe , S Saitoh , S Takagi (2005) Influence of gender, age and renal function on plasma adiponectin level: The Tanno and Sobetsu study. Eur J Endocrinol 153, 9198.

88.K Brochu-Gaudreau , C Rehfeldt , R Blouin (2010) Adiponectin action from head to toe. Endocrine 37, 1132.

89.TS Tsao , E Tomas , HE Murrey (2003) Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways . J Biol Chem 278, 5081050817.

90.Y Wang , KS Lam , MH Yau (2008) Post-translational modifications of adiponectin: Mechanisms and functional implications. Biochem J 409, 623633.

91.P Marques-Vidal , M Bochud , F Paccaud (2010) Distribution of plasma concentrations of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol 72, 3846.

92.H Nishizawa , I Shimomura , K Kishida (2002) Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51, 27342741.

93.M Adamczak , E Rzepka , J Chudek (2005) Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 62, 114118.

94.SS Cohen , MD Gammon , LB Signorello (2011) Serum adiponectin in relation to body mass index and other correlates in black and white women. Ann Epidemiol 21, 8694.

95.T Kadowaki & T Yamauchi (2005) Adiponectin and adiponectin receptors. Endocr Rev 26, 439451.

96.K Hotta , T Funahashi , Y Arita (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 15951599.

97.M Matsubara , S Maruoka & S Katayose (2002). Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87, 27642769.

98.B Nellemann , LC Gormsen , JS Christiansen (2010) Postabsorptive VLDL-TG fatty acid storage in adipose tissue in lean and obese women. Obesity (Silver Spring) 18, 13041311.

99.M Schittmayer & R Birner-Gruenberger (2009) Functional proteomics in lipid research: Lipases, lipid droplets and lipoproteins. Journal of Proteomics 72, 10061018.

100.R Ganguly , K Schram , X Fang (2011) Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes. Endocrinology 152, 247254.

101.A Mohamadkhani , K Sayemiri , R Ghanbari (2010) The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection. Virol J 7, 228.

102.IM Heid , SA Wagner , H Gohlke (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma concentrations and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55, 375384.

103.WS Yang & LM Chuang (2006) Human genetics of adiponectin in the metabolic syndrome. J Mol Med 84, 112121.

104.T Kyriakou , LJ Collins , NJ Spencer-Jones (2008) Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet 53, 718727.

105.F Vasseur , N Helbecque , C Dina (2002) Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone concentrations and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11, 26072614.

106.F Mousavinasab , T Tahtinen , J Jokelainen (2006). Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 87, 147151.

107.JG Woo , LM Dolan , R Deka (2006) Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. Diabetes 55, 523529.

108.N Bouatia-Naji , D Meyre , S Lobbens (2006) ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55, 545550.

109.A Petrone , S Zavarella , A Caiazzo (2006) The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity (Silver Spring) 14, 14981504.

110.JL Gonzalez-Sanchez , CA Zabena , MT Martinez-Larrad (2005) An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13, 807812.

111.V Mackevics , IM Heid , SA Wagner , (2006) The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur J Hum Genet 14, 349356.

113.K Hara , P Boutin , Y Mori (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51, 536540.

114.E Filippi , F Sentinelli , V Trischitta (2004) Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 12, 199205.

115.BD Chiodini , C Specchia , F Gori (2010) Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: An association study in an Italian population. Ther Adv Cardiovasc Dis 4, 223230.

116.C Menzaghi , T Ercolino , R Di Paola (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51, 23062312.

117.C Menzaghi , T Ercolino , L Salvemini (2005) Lack of evidence for interaction between APM1 and PPARgamma2 genes in modulating insulin sensitivity in nondiabetic Caucasians from Italy. J Intern Med 257, 315331.

118.L Melistas , CS Mantzoros , M Kontogianni (2009) Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol 161, 845852.

119.MT Berthier , A Houde , M Cote (2005) Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men. J Lipid Res 46, 237244.

120.O Ukkola , E Ravussin , P Jacobson (2003) Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 52, 881884.

121.JL Beebe-Dimmer , KA Zuhlke , AM Ray (2010) Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis 13, 362368.

122.G Dolley , S Bertrais , V Frochot (2008) Promoter adiponectin polymorphisms and waist/hip ratio variation in a prospective French adults study. Int J Obes (Lond) 32, 669675.

123.D Warodomwichit , J Shen , DK Arnett (2009) ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: The GOLDN study. Obesity (Silver Spring) 17, 510517.

125.JF Ferguson , CM Phillips , AC Tierney (2010) Gene-nutrient interactions in the metabolic syndrome: Single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr 91, 794801.

126.B Kim , Y Jang , JK Paik (2010). Adiponectin gene polymorphisms are associated with long-chain omega3-polyunsaturated fatty acids in serum phospholipids in nondiabetic Koreans. J Clin Endocrinol Metab 95, E347E351.

127.M Iwaki , M Matsuda , N Maeda (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 16551663.

128.N Maeda , M Takahashi , T Funahashi (2001) PPAR{gamma} ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 20942099.

130.K Esposito , A Pontillo , C Di Palo (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA 289, 17991804.

131.M Yannakoulia , N Yiannakouris , S Bluher (2003) Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88, 17301736.

132.E Arvidsson , N Viguerie , I Andersson (2004) Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 53, 19661971.

133.PW Peake , AD Kriketos , GS Denyer (2003) The postprandial response of adiponectin to a high-fat meal in normal and insulin-resistant subjects. Int J Obes Relat Metab Disord 27, 657662.

135.A AlSaleh , SD O'Dell , GS Frost (2011) Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. Am J Clin Nutr 94, 18.

136.LM Sanderson , PJ de Groot , GJ Hooiveld (2008) Effect of synthetic dietary triglycerides: A novel research paradigm for nutrigenomics. PLoS ONE 3, e1681, 111.

137.EH Yeung , LJ Appel , ER Miller III (2010) The effects of macronutrient intake on total and high-molecular weight adiponectin: Results from the OMNI-Heart trial. Obesity (Silver Spring) 18, 1632–1163.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: